Phase II Study of STA-2 in Patients With Chronic Stable Angina

• Status: Completed
• Trial end date: 2008-06-01

Summary

The objectives of this study are to evaluate the efficacy, pharmacological activities and safety of STA-2 in the treatment of chronic stable angina.

• Phase: Phase 2

Details

• Lead Sponsor: Sinphar Pharmaceutical Co., Ltd